loadpatents
Patent applications and USPTO patent grants for Finlay; William James Jonathan.The latest application filed is for "csf1r binding agents".
Patent | Date |
---|---|
Method for treating cancer with c-kit antibodies Grant 11,377,493 - Finlay July 5, 2 | 2022-07-05 |
Method of using anti-CD47 antibody molecules Grant 11,370,840 - Finlay June 28, 2 | 2022-06-28 |
Csf1r Binding Agents App 20210301026 - Finlay; William James Jonathan | 2021-09-30 |
De-immunised Anti-erbb3 Antibodies App 20210189003 - Finlay; William James Jonathan | 2021-06-24 |
Cd47 Binding Agents App 20210179711 - Finlay; William James Jonathan | 2021-06-17 |
De-immunised anti-ERBB3 antibodies Grant 10,975,165 - Finlay April 13, 2 | 2021-04-13 |
Pd1 Binding Agents App 20210101981 - Finlay; William James Jonathan | 2021-04-08 |
Pd1 Binding Agents App 20210047415 - Finlay; William James Jonathan | 2021-02-18 |
Humanized Antibodies App 20210040182 - Finlay; William James Jonathan ;   et al. | 2021-02-11 |
Anti C-met Antibodies App 20210009694 - Finlay; William James Jonathan | 2021-01-14 |
PD1 binding agents Grant 10,858,434 - Finlay December 8, 2 | 2020-12-08 |
PD1 binding agents Grant 10,858,435 - Finlay December 8, 2 | 2020-12-08 |
De-immunised Anti-erbb3 Antibodies App 20200339702 - Finlay; William James Jonathan | 2020-10-29 |
Pd1 Binding Agents App 20200332006 - Finlay; William James Jonathan | 2020-10-22 |
Pd1 Binding Agents App 20200317785 - Finlay; William James Jonathan | 2020-10-08 |
C-kit Antibodies App 20200283521 - Finlay; William James Jonathan | 2020-09-10 |
Binding Agents App 20200277375 - Finlay; William James Jonathan | 2020-09-03 |
Anti-CD47 antibody molecules Grant 10,683,350 - Finlay | 2020-06-16 |
Humanized antibodies Grant 10,647,756 - Finlay , et al. | 2020-05-12 |
C-KIT antibodies Grant 10,611,838 - Finlay | 2020-04-07 |
C-kit Antibodies App 20200010548 - Finlay; William James Jonathan | 2020-01-09 |
Synthetic Library Of Specific Binding Molecules App 20200002403 - BARELLE; Caroline Jane ;   et al. | 2020-01-02 |
Binding Agents App 20190375846 - Finlay; William James Jonathan | 2019-12-12 |
Binding Agents App 20190375840 - Finlay; William James Jonathan | 2019-12-12 |
Isolation of therapeutic target specific VNAR domains to ICOSL Grant 10,472,410 - Barelle , et al. Nov | 2019-11-12 |
Binding agents Grant 10,457,736 - Finlay Oc | 2019-10-29 |
Synthetic library of specific binding molecules Grant 10,202,438 - Barelle , et al. Feb | 2019-02-12 |
Binding Agents App 20190010241 - Finlay; William James Jonathan | 2019-01-10 |
Humanized Antibodies App 20170073395 - Finlay; William James Jonathan ;   et al. | 2017-03-16 |
Compatible display vector systems Grant 9,523,092 - Hufton , et al. December 20, 2 | 2016-12-20 |
Therapeutic Antibody App 20160207991 - Bloom; Laird ;   et al. | 2016-07-21 |
Synthetic Library Of Specific Binding Molecules App 20160176951 - BARELLE; Caroline Jane ;   et al. | 2016-06-23 |
Isolation Of Therapeutic Target Specific Vnar Domains To Icosl App 20160068600 - BARELLE; Caroline Jane ;   et al. | 2016-03-10 |
Compatible Display Vector Systems App 20130217597 - HUFTON; Simon Evan ;   et al. | 2013-08-22 |
Compatible display vector systems Grant 8,313,942 - Hufton , et al. November 20, 2 | 2012-11-20 |
Humanized Anti-rage Antibody App 20100143349 - Hufton; Simon Evan ;   et al. | 2010-06-10 |
Single Chain Antibody Library Design App 20100124764 - Hufton; Simon Evan ;   et al. | 2010-05-20 |
Compatible Display Vector Systems App 20100120634 - HUFTON; Simon Evan ;   et al. | 2010-05-13 |
Compatible Display Vector Systems App 20100113304 - Hufton; Simon Evan ;   et al. | 2010-05-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.